tremelimumab astrazeneca
astrazeneca ab - tremelimumab - karcinóma, nem kissejtes tüdő - daganatellenes szerek - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - daganatellenes szerek - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
aricept 10 mg filmtabletta
pfizer kft. - donepezil -
aricept 5 mg filmtabletta
pfizer kft. - donepezil -
donectil 5 mg filmtabletta
pharmaswiss ceska republika s.r.o - donepezil -
donecept 5 mg filmtabletta
teva b.v. - donepezil -
donecept 10 mg filmtabletta
teva b.v. - donepezil -
palixid 5 mg filmtabletta
richter gedeon nyrt. - donepezil -
palixid 10 mg filmtabletta
richter gedeon nyrt. - donepezil -
yasnal 5 mg filmtabletta
krka d.d., - donepezil -